Skip to main content
. 2020 Mar 17;4(3):449–455. doi: 10.1002/bjs5.50273

Table 1.

Baseline patient and disease characteristics

2016–2019 (n = 50) 2000–2015 (n = 141) P
Age (years) * 65(11) 63(10) 0·231§
Sex ratio (F : M) 21 : 29 53 : 88 0·582
BMI (kg/m 2 ) 23 (22–26) 22 (20–26) 0·974
ECOG performance status 0·285
0 30 (60) 98 (69·5)
1 13 (26) 35 (24·8)
2 6 (12) 7 (5·0)
3 1 (2) 1 (0·7)
ASA grade 0·190
I 5 (10) 30 (21·3)
II 37 (74) 88 (62·4)
III 8 (16) 23 (16·3)
Jaundice at presentation 33 (66) 104 (73·8) 0·295
Biliary drainage 36 (72) 123 (87·2) 0·013
Type of biliary drainage 0·242
Percutaneous transhepatic 5 (14) 11 (8·9)
Endoscopic 23 (64) 67 (54·5)
Both 8 (22) 45 (36·6)
Preoperative cholangitis 23 (46) 47 (33·3) 0·101
Bismuth type 0·134
I 0 (0) 0 (0)
II 0 (0) 4 (2·8)
IIIA 33 (66) 70 (49·6)
IIIB 9 (18) 44 (31·2)
IV 8 (16) 23 (16·3)
Portal vein embolization 16 (32) 9 (6·4) < 0·001
Resection type 0·432
Left hemihepatectomy 17 (34) 57 (40·4)
Extended left hemihepatectomy 2 (4) 6 (4·3)
Right hemihepatectomy 16 (32) 33 (23·4)
Extended right hemihepatectomy 15 (30) 40 (28·4)
Central/minor liver resection 0 (0) 5 (3·5)
Portal vein reconstruction 8 (16) 38 (27·0) 0·120

Values in parentheses are percentages unless indicated otherwise; values are

*

mean(s.d.) and

median (i.q.r.). ECOG, Eastern Cooperative Oncology Group.

χ2 or Fisher's exact test, except

§

Student's t test and

Mann–Whitney U test.